top of page
Rinnit logo – modern health products and health news

What Is MIS-C in Kids? A Plain-Language Guide to the Rare Condition Linked to COVID-19

Oct 14
9 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer: Key Facts About MIS-C

MIS-C is a rare, serious condition in which a child's immune system overreacts to COVID-19, causing bodywide inflammation, usually within two months of infection. Signs include fever for 4 to 6 days, rash, red eyes, belly pain and heart problems. Call 911 for trouble breathing, chest pain or confusion. Vaccination may help prevent it. [1]

Question

Answer

What it is

A rare, serious condition where a child's immune system reacts too strongly to COVID-19, causing bodywide inflammation.

When it happens

Usually within two months after a child has COVID-19 or was around someone who had it; most often in children ages 5 to 12.

What it looks like

Fever for 4 to 6 days, rash, red eyes, red or swollen lips and tongue, swollen hands or feet, belly pain, vomiting, diarrhea, and heart problems.

When it's an emergency

Severe belly pain, chest pain or pressure, trouble breathing, gray or blue skin or lips, new confusion, or trouble staying awake — call 911 right away.

How it can be prevented

The COVID-19 vaccine may help prevent MIS-C, along with masking, ventilation, hand hygiene, and avoiding sick people when cases are high in your area.

What the research says

  • Two doses of the Pfizer-BioNTech vaccine strongly protected teens against MIS-C. In a US test-negative case-control study at 24 pediatric hospitals (102 teens with MIS-C and 181 hospitalized controls aged 12–18, during Delta variant predominance), two doses received at least 28 days before admission were 91% effective against MIS-C (95% CI 78%–97%). All 38 patients with MIS-C who needed life support were unvaccinated. (Zambrano et al., MMWR, 2022) [7]

  • MIS-C often needs intensive care, but heart problems usually improve. In a JAMA case series of 1,116 US children and adolescents (539 with MIS-C), 73.8% of those with MIS-C were admitted to intensive care and 1.9% died during hospitalization. Among those with reduced left ventricular function (34.2%) and coronary artery aneurysm (13.4%), an estimated 91.0% and 79.1%, respectively, returned to normal within 30 days. (Feldstein et al., JAMA, 2021) [8]

What Is MIS-C?

Multisystem inflammatory syndrome in children — called MIS-C for short — is a rare but serious illness linked to coronavirus disease 2019 (COVID-19). [1]

Most children with COVID-19 have only mild illness. But with MIS-C, the body's immune system reacts too strongly. Instead of just fighting the virus, the overreaction causes damage to the body. [1]

MIS-C usually happens within two months after a child has had COVID-19 or has been around someone who had the illness. Most children with MIS-C get better over time, but some kids quickly get worse. MIS-C can be a life-threatening illness and, sometimes, causes death. [1]

What's the Difference Between MIS-C and Normal COVID-19 in Kids?

In most children, COVID-19 causes mild illness. In MIS-C, the problem isn't the virus itself — it's the immune system's response. The immune system reacts too strongly and injures the body's own organs. [1]

Here is a simple way to picture it: with mild COVID-19, the immune system fights the virus and calms down. With MIS-C, the immune system stays switched "on" far too hard and far too long, causing inflammation across several organ systems at once.

Comparison diagram of typical mild COVID-19, where the immune system fights the virus and calms down, versus MIS-C, where the immune system reacts too strongly and damages the heart, lungs, stomach, and blood vessels – rinnit.com

What Are the Symptoms of MIS-C?

MIS-C causes serious symptoms that are often treated in the hospital. Not all children have the same symptoms. [1]

If no other diagnosis fits, healthcare professionals may diagnose MIS-C when a child meets four conditions: [1]

#

What must be present

1

The child had COVID-19 or was in close contact with someone who recently had it [1] [2]

2

A fever, which may last 4 to 6 days [1]

3

A blood test showing a high level of inflammation in the body [1] [2]

4

Symptoms of health issues within two other organ systems [1] [2]

Examples of symptoms in other organ systems include:

Organ system

Possible symptoms

Heart

Trouble with how the heart pumps blood, or damage to the heart arteries [1] [2]

Skin and eyes

A rash, red eyes, redness or swelling of the lips or tongue; swollen hands or feet [1] [2]

Digestive system

Belly pain, vomiting, or diarrhea [1] [2]

Blood

Blood test results outside the reference range — for example, too many immune cells or too few platelets (the blood cells that help clotting) [1]

Whole body

Shock — a bodywide response to the immune system that affects blood vessels and the heart [1]

Four-part MIS-C diagnosis checklist: recent COVID-19 exposure, fever lasting 4 to 6 days, blood test showing high inflammation, and symptoms in two other organ systems such as the heart, skin, or digestive system – rinnit.com

When Should I Call 911?

Call 911 or your local emergency number right away if your child shows any emergency warning signs of MIS-C. [1]

Emergency warning sign

What to watch for

Severe belly pain

Severe belly pain [1]

Chest pain or pressure

Pain or a feeling of pressure in the chest [1]

Breathing problems

Trouble breathing [1]

Skin color changes

Gray or blue skin, lips, or nail beds [1]

New confusion

Sudden confusion or not making sense [1]

Extreme sleepiness

Trouble waking up or staying awake [1]

Six emergency warning signs of MIS-C: severe belly pain, chest pain or pressure, breathing problems, gray or blue skin lips or nail beds, new confusion, and trouble waking up or staying awake, with a call 911 callout – rinnit.com

When Should I See a Doctor?

Get care right away if your child has severe belly pain, pain or pressure in the chest, trouble breathing, new confusion, or trouble waking up or staying awake. Take your child to the nearest emergency room or call 911 or your local emergency number. [1]

If your child isn't severely ill but has symptoms of MIS-C, contact your child's healthcare professional right away for advice. [1]

What Causes MIS-C?

The exact cause of MIS-C is not known. Many children with MIS-C have had a recent infection with the COVID-19 virus. Some may have a current infection with the virus. [1]

Who Is at Higher Risk?

MIS-C most often affects children ages 5 to 12. Older and younger kids can get MIS-C, but it's rare. [1]

Can MIS-C Cause Long-Term Problems?

MIS-C is a possible complication of COVID-19. Without quick diagnosis and treatment, MIS-C can cause serious symptoms in vital organs, such as the heart. Rarely, MIS-C may cause lasting health issues or death. [1]

That is why fast action matters: most children with MIS-C get better over time, but some kids quickly get worse. [1]

Can MIS-C Be Prevented?

Getting a COVID-19 vaccine may help prevent MIS-C. [1] Four COVID-19 vaccines are FDA-approved in the United States for the 2026–2027 season, all updated to target the XFG variant. Each is approved by age, and for people younger than 65 the approvals cover those with at least one underlying condition that raises the risk of severe COVID-19. [5] [6]

Vaccine

Age range

Key detail

Spikevax (Moderna)

6 months and older [5]

Approved for adults 65 and older and for younger people at higher risk of severe COVID-19 [5] [6]

Comirnaty XFG (Pfizer-BioNTech)

5 years and older [5]

Approved for adults 65 and older and for ages 5 through 64 with at least one high-risk condition [5] [6]

mNEXSPIKE (Moderna)

12 years and older [5]

Approved for adults 65 and older and for ages 12 through 64 with at least one high-risk condition [5] [6]

Nuvaxovid (Novavax)

12 years and older [5]

Approved for adults 65 and older and for younger people at higher risk; the only non-mRNA option [5]

Here is what else to know about vaccination:

  • COVID-19 vaccines protect against serious illness and the need for hospital care due to COVID-19. Serious side effects from the COVID-19 vaccine are extremely rare. [1]

  • The American Academy of Pediatrics' 2026–2027 recommendations call for the 2026–2027 COVID-19 vaccine for all infants and children aged 6 through 23 months who have no contraindications, and a single dose for children aged 2 through 18 years who are not considered at risk of severe COVID-19 if a parent or guardian wants their protection. Children at higher risk have separate recommendations. [3] [4]

  • Dose schedules are updated each season. Ask your child's healthcare professional which doses your child needs.

  • The COVID-19 vaccine can be given to children on the same day as other vaccines if the timing is correct. [1]

How Can I Help Control the Spread?

If many people in your area have COVID-19, a few steps can help control the spread of the virus: [1]

Prevention step

Details

Wear a mask indoors

Wear a well-fitting mask indoors in public places when COVID-19 is spreading in your area. Never put a mask on a child younger than age 2 or a child with a disability who can't safely wear one [1]

Move the air

Open windows or doors, use fans, and use air filters to help clean the air [1]

Keep your distance

Stay apart from anyone who is sick or has symptoms; spread out in crowded indoor spaces, especially where airflow is poor [1]

Clean often

Keep hands clean, and regularly clean and disinfect your home [1]

What is the bottom line on MIS-C in kids?

MIS-C is a rare but serious condition where a child's immune system reacts too strongly after COVID-19, causing inflammation that can hurt the heart, skin, eyes, digestive system, and more. It most often affects children ages 5 to 12 and usually shows up within two months of a COVID-19 infection or exposure. The good news: most children get better over time. The urgent news: the warning signs — severe belly pain, chest pain or pressure, breathing trouble, gray or blue skin, new confusion, and trouble staying awake — mean you should call 911 right away. COVID-19 vaccination may help prevent MIS-C, and simple steps like masking, fresh air, and hand hygiene help control the spread. [1]

Take the Next Step

If your child recently had COVID-19 or was around someone who did, and now has a fever lasting several days plus rash, red eyes, belly pain, or unusual tiredness, don't wait it out. Contact your child's healthcare professional right away — and call 911 for any of the six emergency warning signs. Rinnit.com's plain-language guides help you understand what each warning sign means, what the diagnosis process looks like, and what questions to ask at your appointment, so you can act fast and feel prepared.

If your child hasn't had a COVID-19 vaccine yet, ask your pediatrician whether the 2026–2027 vaccine is right for their age and health — vaccination may help prevent MIS-C, and serious side effects are extremely rare.

Frequently Asked Questions

What is MIS-C in simple terms?

MIS-C (multisystem inflammatory syndrome in children) is a rare, serious condition linked to COVID-19 where the immune system reacts too strongly and damages the body instead of just fighting the virus. [1]

How soon after COVID-19 does MIS-C appear?

MIS-C usually happens within two months after a child has had COVID-19 or has been around someone who had the illness. [1]

Which children are most at risk for MIS-C?

MIS-C most often affects children ages 5 to 12. Older and younger kids can get it, but it's rare. [1]

What are the main symptoms of MIS-C?

Symptoms can include a fever lasting 4 to 6 days, rash, red eyes, red or swollen lips or tongue, swollen hands or feet, belly pain, vomiting, diarrhea, and problems with how the heart pumps blood. Blood tests often show a high level of inflammation. [1]

When should I call 911 for a child with possible MIS-C?

Call 911 right away for severe belly pain, chest pain or pressure, trouble breathing, gray or blue skin or lips or nail beds, new confusion, or trouble waking up or staying awake. [1]

What causes MIS-C?

The exact cause is not known, but many children with MIS-C have had a recent COVID-19 infection, and some have a current infection. [1]

Can my child get better after MIS-C?

Yes. Most children with MIS-C get better over time. However, some kids quickly get worse, and without quick diagnosis and treatment the condition can cause serious problems in vital organs such as the heart — and rarely, lasting health issues or death. [1]

Can vaccination help prevent MIS-C?

Getting a COVID-19 vaccine may help prevent MIS-C. [1] Four vaccines (Spikevax, Comirnaty XFG, mNEXSPIKE, and Nuvaxovid) are FDA-approved for the 2026–2027 season by age and health status, and serious side effects are extremely rare. [1] [5] Masking, ventilation, distancing, and hand hygiene also help control the spread. [1]

Related Reading

Read next on Rinnit.com:

References

  1. Mayo Clinic Staff. Multisystem inflammatory syndrome in children (MIS-C) and COVID-19 - Symptoms & causes. Mayo Clinic. August 31, 2026. https://www.mayoclinic.org/diseases-conditions/mis-c-in-kids-covid-19/symptoms-causes/syc-20502550

  2. Centers for Disease Control and Prevention. Case Definitions and Reporting. CDC. February 19, 2026. https://www.cdc.gov/mis/hcp/case-definition-reporting/

  3. American Academy of Pediatrics. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement. Pediatrics. 2026. PMID 42683684. https://doi.org/10.1542/peds.2026-079045

  4. Guideline Central. 2026 AAP COVID-19 Vaccines in Infants, Children, and Adolescents 2026-2027 Statement Now Available. Guideline Central. September 5, 2026. https://www.guidelinecentral.com/insights/sep-2026-aap-covid19infantschildrenadolescents-guideline-spotlight/

  5. Epocrates. Four FDA-approved COVID vaccines for the 2026–27 season. Epocrates. August 31, 2026. https://www.epocrates.com/online/article/four-fda-approved-covid-vaccines-for-the-2026-27-season

  6. Contagion Live. FDA Approves Multiple COVID-19 Vaccines With Protection Against XFG variant. Contagion Live. August 28, 2026. https://www.contagionlive.com/view/fda-approves-3-covid-19-vaccines-with-protection-against-xfg-variant

  7. Zambrano LD, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52-58. PMID 35025852. https://doi.org/10.15585/mmwr.mm7102e1

  8. Feldstein LR, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074-1087. PMID 33625505. https://doi.org/10.1001/jama.2021.2091

Medical disclaimer

This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions. In an emergency, call 911 or your local emergency number.

Comments


bottom of page